Bladder Cancer Advocacy Network Announces $600,000 in Awards to Propel Bladder Cancer Research Innovation

Bethesda, Maryland--(Newsfile Corp. - July 13, 2021) - Today, the Bladder Cancer Advocacy Network (BCAN) announced the two recipients of its prestigious Bladder Cancer Research Innovation Award. This is the first year ever in which two awards have been granted. This year's awardees are Weiguo Cui, Ph.D., an Associate Investigator at the Versiti Blood Research Institute and an Associate Professor of Microbiology and Immunology at the Medical College of Wisconsin, and John K. Lee, M.D., Ph.D., an Assistant Professor in the Human Biology Division at the Fred Hutchinson Cancer Research Center. These awards are part of the more than $6 million in research grants that BCAN has awarded to end this disease that impacts the more than 600,000 people in the United States who are living with it.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Bladder cancer is among the most commonly diagnosed cancers in America.
  • BCAN funds research to help end this disease impacting more than 600,000 Americans.
  • 2021 is the first year that BCAN has made two Research Innovation Award grants, totaling $600,000.

Cannot view this image? Visit:

Click image above to view full announcement.


About BCAN

BCAN was founded in 2005 and is the only national advocacy organization devoted to advancing bladder cancer research and supporting those impacted by the disease.

BCAN is on the front-lines advocating for greater public awareness and increased funding for research to identify effective treatments and eventually, a cure for bladder cancer.

Each year, BCAN provides thousands of patients, caregivers and the medical community with the educational resources and support services they need to navigate their bladder cancer journeys. BCAN works collaboratively with the medical and research professionals who are dedicated to the prevention, diagnosis and treatment of bladder cancer and empowers the patient community by allowing them to share experiences with others, and to participate in building awareness of the need for a cure.


Mark Story

Source: Bladder Cancer Advocacy Network.


To view the source version of this press release, please visit

Back to news